in the news

Recent Rosacea Blog Posts

Mirvaso Rebound Flushing makes the news

In a followup article on François Fournier, the head of Galderma USA, the Dallas Forth Worth Daily raises the topic of rebound flushing from Mirvaso. Whilst only quoting one online forum posting, the author Bradford Pearson highlights what he calls the mixed response to the newly released topical Mirvaso. Indeed it is a question that […]

Continue Reading

Mirvaso to be a $100 million drug for Galderma

A revealing interview with the Galderma USA President Francois Fournier has just been published by the Dallas Fort Worth Healthcare Daily. This publication, `D HEALTHCARE Daily’ takes a keen interest in Galderma as the company’s US headquarters are in Forth Worth, TX. In the interview Fournier gives some interesting insights into the research and development […]

Continue Reading

American Acne & Rosacea Society, too close to Big Pharma ?

A really interesting post over at `medpage TODAY’ is asking just what is the American Acne & Rosacea Society is up to, and asking the question are they too close to the bigPharma that they are funded by. We first learned of the existence of the AARS in 2006. Whilst it was puzzling as to […]

Continue Reading

North East US has the most Rosacea Sufferers

An interesting graph published on the NRS Blog shows that there is a high concentration of rosacea sufferers in the North East of the USA. The graph shows the residents of New England have the highest incidence of rosacea in the country. Puts a different spin on red states vs. blue states eh? The NRS […]

Continue Reading

Step backwards for Generic Oracea. Invalid patents are back

For those following the saga of the possible availability of Generic Oracea in the future, another twist today. Two of the patents that were previously ruled invalid and thus unable to protect Galderma’s product, have now been ruled no longer invalid. This legal ruling will no doubt embolden Galderma that their profitable product Oracea can […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.